Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers .
Case opinion for US Supreme Court BRUESEWITZ ET AL. v. ... It granted Wyeth summary judgment, holding that the relevant Pennsylvania law was preempted ...
Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... The Bruesewitzes filed a lawsuit against Wyeth in state court in Pennsylvania.
LPS and SE were significantly different than placebo for all active treatments (p ... Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK. .... Eszopiclone 2.5 mg also demonstrated significant differences versus .... Vanda, and Wyeth-Ayerst; has consulted for Aventis, Boehringer Ingelheim, ...
Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T. Evaluation of the .... All subjects who received at least 1 dose of study medication were included in the intent-to-treat analysis. .... PSG-determined latency to persistent sleep: ramelteon vs placebo treatments. ..... Brzezinski A, Vangel MG, Wurtman RJ, et al.
Modafinil was well tolerated versus placebo, with headache (34% vs 23%, respectively), nausea (11% vs 3%), and ... Roth T; Schwartz JRL; Hirshkowitz M et al.
37.8 (3.4) min for placebo, (P < 0.0001 for both doses vs placebo), and by 51.7 ( 3.4) min (P = 0.01) and 48.0 (3.6) min ...... McCall WV, Erman M, Krystal AD, et al.
Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting .... [PubMed]; Hoddes E, Zarcone V, and Smythe H. et al. ..... [ PubMed]; Schwartz JRL, Hirshkowitz M, and Erman MK. et al. ... GlaxoSmithKline, Sanofi-Synthelabo, and Wyeth and is a member of the speakers or advisory boards ...
Jul 20, 2010 ... Zaleplon is a pyrazolopyrimidine hypnotic used for the treatment of insomnia. Zaleplon binds preferentially at the α1β2γ2 subunit of gamma ...